Kuehne + Nagel extends overland pharma cross dock platform in Contern, Luxembourg

Kuehne + Nagel extends overland pharma cross dock platform in Contern, Luxembourg

    • Extension of the European overland pharma cross dock platform in Luxembourg for more frequent departures and faster transit times
    • Complete coverage to all European destinations
    • Enhanced real time monitoring solutions for temperature sensitive pharma shipments

Contern, Luxembourg, 26-Mar-2018 — /EuropaWire/ — Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s European overland business. With the extension of the European overland cross dock platform in Contern and the integration of telematics data of key providers Kuehne + Nagel strengthens its position in the European market for pharma solutions.

Uwe Hött, Senior Vice President Overland Europe at Kuehne + Nagel, said: “Industry specific services for customers from the pharma & healthcare industry mark a key factor of Kuehne + Nagel’s success story in overland business. The investment into our Luxembourg pharma platform and the integration of telematics data of qualified key transport partners contribute significantly towards our overall strategy for the pharma industry with a special focus on temperature controlled transportation for both FTL and LTL. The extension of the Contern facility will enhance providing industry leading services with increased capacity for our customers.“

The platform in Contern is part of Kuehne + Nagel’s KN PharmaChain. KN PharmaChain is a multi-modal logistics solution for temperature-controlled door-to-door transportation which allows accurate traceability of the deliveries and intensive, proactive risk management.

The facility offers a complete coverage to all European destinations with competitive lead times and an industry leading GDP certified infrastructure. The new platform increases the capacity for loading and unloading pharmaceutical products under temperature controlled warehousing conditions and in a completely closed environment. The GDP certified cross dock is divided into a zone of 2°-8°C and one of 15-25°C with 4.000 square metres dedicated for the pharma sector.

Furthermore the platform has several features that guarantee the best environment for the handling of pharmaceutical products like

  • cool rooms and flooring enhancing the quality of pharma handling,
  • cooling and heating systems independent of electricity running on redundant cooling machines,
  • 24/7/365 warehouse temperature monitoring linked to an external surveillance center,
  • computer validated temperature monitoring and warning systems,
  • own dedicated secured and guarded truck parking area nearby the warehouse
  • fully CCTV and access controlled area.

With an increasing number of state of the art bi-thermo temperature controlled trailers, either own assets or operated by qualified partners, Kuehne + Nagel aims at seamless services for temperature controlled FTL and LTL shipments across Europe. The integration of telematics data of key transport partners into Kuehne + Nagel`s platform KN Login marks another step towards full visibility to pharma customers.

SOURCE: KUEHNE + NAGEL INC

Media Contact
Add me on LinkedIn (opens in new window) Follow me on Xing (opens in new window)
Karl Olaf Petters
Head of Corporate Communications
karl.olaf.petters@kuehne-nagel.com
+41 447869526

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.